Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(21%)
Results Posted
14%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
12
86%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting2
Terminated1
Not yet recruiting1
unknown1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (7.7%)
N/A12 (92.3%)

Trials by Status

recruiting214%
terminated17%
completed750%
not_yet_recruiting17%
unknown17%
enrolling_by_invitation17%
active_not_recruiting17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14